已收盤 05-15 16:00:00 美东时间
-0.020
-1.16%
Ainos (NASDAQ:AIMD) reported quarterly losses of $(0.41) per share. This is a 60.95 percent increase over losses of $(1.05) per share from the same period last year. The company reported $161.000 in sales this quarter.
05-14 05:32
2026 Identified as a Key Scale-Up Phase with Expanding Market Verticals and Accelerating Data Flywheel
04-17 20:06
Gainers Republic Power Group (NASDAQ:RPGL) stock moved upwards by 101.5% to $1...
04-15 05:05
Ainos (NASDAQ:AIMD) reported quarterly losses of $(0.85) per share. This is a 34.62 percent increase over losses of $(1.30) per share from the same period last year. The company reported $11.120 thousand in sales this
03-31 06:12
Ainos FY25 net loss narrows 0.6% to $14.8 million Ainos posted a net loss of USD 15 million for 2025. Revenue jumped 499% to USD 124,157, mainly reflecting progress in AI Nose commercialization. Gross margin turned positive to 82.9%. Early-stage AI Nose deployments launched in semiconductor environm
03-30 21:05
Ainos plans 200 AI Nose deployments in front-end wafer fabs in 1Q26 Ainos said it plans to deploy about 200 AI Nose systems in front-end wafer fabrication facilities in 1Q26. The company said Phase 1 of its agreement with ASE covers 1,400 AI Nose systems and is targeted for completion in 2Q26. Ainos
03-12 20:31
Gainers PicoCELA (NASDAQ:PCLA) stock moved upwards by 10.2% to $2.81 during Mo...
03-10 05:05
Ainos Confirms Initial Order for 1,400 AI Nose Systems Under Three-Year Subscription Deal Ainos Inc. said it has a confirmed initial order for 1,400 AI Nose systems, which the company said will activate recurring subscription revenue under a three-year service structure totaling about $2.1 million.
03-02 21:30
Ainos shares are trading lower. The company announced interim results from its ...
02-18 01:41
Ainos Reports Promising Interim Results for VELDONA in Feline Gingivostomatitis Trial Ainos Inc. announced interim results from an ongoing open-label, multi-dose clinical trial evaluating VELDONA, a low-dose oral interferon alpha formulation, for the treatment of Feline Chronic Gingivostomatitis (FC
02-17 21:01